There were 2,117 press releases posted in the last 24 hours and 430,064 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Cara Therapeutics Announces Summary Data From Phase 1 Trial of Oral CR845 in Hemodialysis Patients with Chronic Kidney Disease

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image